Kornitzer Capital Management Inc Johnson & Johnson Transaction History

Kornitzer Capital Management Inc

$5.1 Billion
Q2 2024

A detailed history of Kornitzer Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 344,918 shares of JNJ stock, worth $55.7 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

344,918

Previous 348,168 0.93%

Holding current value

$55.7 Million

Previous $55.1 Million 8.47%

% of portfolio

0.99%

Previous 1.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$144.38 - $157.78 $469,235 - $512,785	-3,250 Reduced 0.93%	344,918 $50.4 Million
Q1 2024 May 01, 2024	SELL	$155.22 - $162.74 $42,840 - $44,916	-276 Reduced 0.08%	348,168 $55.1 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $263,536 - $287,572	-1,810 Reduced 0.52%	348,444 $54.6 Million
Q3 2023 Oct 31, 2023	SELL	$155.75 - $174.48 $157,930 - $176,922	-1,014 Reduced 0.29%	350,254 $54.6 Million
Q2 2023 Aug 01, 2023	BUY	$154.35 - $166.11 $654,598 - $704,472	4,241 Added 1.22%	351,268 $58.1 Million
Q1 2023 May 09, 2023	BUY	$151.05 - $180.26 $2.3 Million - $2.75 Million	15,251 Added 4.6%	347,027 $53.8 Million
Q4 2022 Feb 02, 2023	BUY	$160.2 - $179.79 $190,638 - $213,950	1,190 Added 0.36%	331,776 $58.6 Million
Q3 2022 Nov 03, 2022	SELL	$161.33 - $179.52 $1.19 Million - $1.32 Million	-7,380 Reduced 2.18%	330,586 $54 Million
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $1.12 Million - $1.24 Million	-6,658 Reduced 1.93%	337,966 $60 Million
Q1 2022 Apr 27, 2022	SELL	$158.14 - $179.59 $1.86 Million - $2.12 Million	-11,781 Reduced 3.31%	344,624 $61.1 Million
Q4 2021 Feb 01, 2022	SELL	$155.93 - $173.01 $378,130 - $419,549	-2,425 Reduced 0.68%	356,405 $61 Million
Q3 2021 Nov 03, 2021	BUY	$161.5 - $179.47 $789,896 - $877,787	4,891 Added 1.38%	358,830 $58 Million
Q2 2021 Jul 30, 2021	SELL	$159.48 - $171.07 $231,405 - $248,222	-1,451 Reduced 0.41%	353,939 $58.3 Million
Q1 2021 Apr 30, 2021	SELL	$153.07 - $170.48 $681,467 - $758,976	-4,452 Reduced 1.24%	355,390 $58.4 Million
Q4 2020 Jan 29, 2021	SELL	$137.11 - $157.38 $2.54 Million - $2.91 Million	-18,512 Reduced 4.89%	359,842 $56.6 Million
Q3 2020 Oct 30, 2020	SELL	$140.38 - $153.83 $1.72 Million - $1.88 Million	-12,222 Reduced 3.13%	378,354 $56.3 Million
Q2 2020 Aug 03, 2020	SELL	$128.81 - $155.51 $1.13 Million - $1.37 Million	-8,792 Reduced 2.2%	390,576 $54.9 Million
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $1.14 Million - $1.58 Million	-10,278 Reduced 2.51%	399,368 $52.4 Million
Q4 2019 Jan 31, 2020	SELL	$127.5 - $146.44 $3.56 Million - $4.08 Million	-27,894 Reduced 6.38%	409,646 $59.8 Million
Q3 2019 Nov 04, 2019	SELL	$126.95 - $142.14 $3.47 Million - $3.89 Million	-27,356 Reduced 5.88%	437,540 $56.6 Million
Q2 2019 Jul 31, 2019	SELL	$131.15 - $144.24 $930,509 - $1.02 Million	-7,095 Reduced 1.5%	464,896 $64.8 Million
Q1 2019 May 01, 2019	SELL	$125.72 - $139.79 $1.18 Million - $1.32 Million	-9,418 Reduced 1.96%	471,991 $66 Million
Q4 2018 Jan 31, 2019	SELL	$122.84 - $147.84 $767,012 - $923,112	-6,244 Reduced 1.28%	481,409 $62.1 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $228,570 - $268,614	-1,880 Reduced 0.38%	487,653 $67.4 Million
Q2 2018 Aug 02, 2018	SELL	$119.4 - $131.76 $264,709 - $292,111	-2,217 Reduced 0.45%	489,533 $59.4 Million
Q1 2018 Apr 30, 2018	SELL	$125.1 - $148.14 $481,635 - $570,339	-3,850 Reduced 0.78%	491,750 $63 Million
Q4 2017 Jan 31, 2018	SELL	$131.22 - $143.62 $3.6 Million - $3.94 Million	-27,460 Reduced 5.25%	495,600 $69.2 Million
Q3 2017 Oct 31, 2017	BUY	$129.47 - $135.38 $67.7 Million - $70.8 Million	523,060	523,060 $68 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $422B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Johnson & Johnson Transaction History